A meta-analysis, including 3,437 patients, showed that the BRAF V600E mutation was correlated with some aggressive clinicopathological features, such as tumor multifocality, extrathyroidal extension, lymph node metastases, and advanced stage of PTMC (29). Here, BRAF is linked to neoplasm.